Healthcare Global at 52-week high on buzz over PE funds jostling for controlling stake
The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.
Read MoreThe three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.
Read MoreMotilal Oswal recommended Neutral rating on Aditya Birla Fashion and Retail with a target price of Rs 260 in its research report dated January 15, 2024.
Read MoreMotilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 2185 in its research report dated January 15, 2024.
Read MoreMotilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated January 15, 2024.
Read MoreMotilal Oswal recommended Neutral rating on Muthoot Finance with a target price of Rs 1440 in its research report dated January 14, 2024.
Read MoreThe current production of PLA in the US and Thailand produces 68 percent lower greenhouse gases
Read More